Skip to content

Phytosterol Supplementation and Lipoprotein Subfractions

Effects of Phytosterol Supplementation on Lipoprotein Subfractions and LDL Particle Quality: Primary Prevention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06127732
Acronym
Phyto
Enrollment
23
Registered
2023-11-13
Start date
2017-05-01
Completion date
2022-01-10
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia, Primary Prevention

Keywords

Phytosterols, Lipoproteins, LDL-subfractions, HDL-subfractions

Brief summary

The goal of this clinical trial was to evaluate the effects of phytosterol supplementation to the diet on lipids, LDL and HDL subfractions, and on the quality of LDL in apparently healthy subjects. The main questions it aims to answer are: * do phytosterols reduce LDL-cholesterol and modify LDL and HDL subfractions? * do phytosterols modify the quality of LDL? Participants were aleatory selected to diet alone (D) or diet plus phytosterols (DP, 2.6 g divided in two doses, with meals) for 12 weeks, followed by a 7-day washout period, where treatments were switched for another 12-weeks.

Detailed description

Military police from the ROTA (Rondas Ostensivas Tobias de Aguiar, N=60), with hypercholesterolemia in primary prevention were recruited. Of those, 27 did not meet entry criteria, 10 were excluded for not following the protocol. Twenty-three individuals were aleatory selected to diet alone (D) or diet plus phytosterols (DP, 2.6 g divided in two doses, with meals) for 12 weeks (w), followed by a 7-day washout period, where treatments were switched for another 12-w. Study was prospective, randomized, open label, cross-over, with parallel arms and blinded endpoints. Anthropometry, food consumption and laboratory parameters were evaluated every 12-w. HDL and LDL subfractions were analyzed by the electrophoresis system in polyacrylamide gel (Lipoprint System®). Plasma LDL was separated by ultracentrifugation and the quality of the LDL analyzed by nonlinear optical response (Z-scan and UV-vis spectroscopy techniques).

Interventions

DIETARY_SUPPLEMENTPhytosterol supplements

Participants were randomized into two groups to receive diet plus phytosterols (DP) for 12 weeks, followed by a 7-day washout period with a second period of intervention, where treatments were switched, and participants received diet alone (D) and were followed for another 12 weeks.

Sponsors

University of Sao Paulo
CollaboratorOTHER
Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective, open-label, crossover intervention study conducted with participants selected by the investigators, and invited to participate in the study.

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* participants of both sexes, aged \>18 and \<65 years, literate, in primary prevention of cardiovascular disease, with LDL-c ≥130mg/dL and \<190 mg/dL and triglycerides \<400 mg/dL.

Exclusion criteria

* secondary causes of dyslipidemia, renal (creatinine \> 2mg/dL), hepatic (AST or ALT \> 1.5 ULN), or metabolic (HbA1c \>8.0%) dysfunction, with BMI \<18.5 or \>40 Kg/m2, recent surgery, disabsortive syndrome, malignancies, under lipid-lowering therapy, unable or unwilling to participate, or with less than 80% adherence to phytosterols

Design outcomes

Primary

MeasureTime frameDescription
Change in total and LDL-cholesterol12 weeksPhytosterol suplementation can reduce by 5-10% plasma levels of total- and LDL-cholesterol

Secondary

MeasureTime frameDescription
Change in LDL subfractions12 weeksPhytosterol suplementation can modify LDL subfractions
Change in HDL subfractions12 weeksPhytosterol suplementation can modify HDL subfractions
Improvement on quality of LDL particle12 weeksPhytosterol supplementation can improve the quality of LDL particle

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026